The Cystic Fibrosis Foundation (CFF) has awarded $5 million to the Cleveland Clinic to continue as the biorepository coordinating…
Articles by Andrea Lobo, PhD
The Clairity Ball — the hallmark annual event of Claire’s Place Foundation — is set to return to…
The events slated for this year’s Cystic Fibrosis Awareness Month aim to celebrate the accomplishments, milestones, and hopes of those…
Children and adolescents with cystic fibrosis (CF) treated with Kaftrio, marketed as Trikafta in the U.S., experienced increases…
Treatment with Trikafta (elexacaftor/tezacaftor/ivacaftor) contributed to a reduction in pulmonary exacerbations requiring hospitalization between 2018 and 2022 among children…
Researchers at the University of California, Los Angeles (UCLA) are developing a gene-editing therapy — designed to be delivered as…
Poor sleep quality is linked to a higher risk of malnutrition in adolescents with cystic fibrosis (CF), suggesting that…
Discoveries into the process underlying protein organization on cell membranes could ultimately lead to new ways to treat cystic fibrosis…
Volatile organic compounds (VOCs) found in breath may be used as biomarkers of lung function and treatment response in children with…
The U.K. Medicines and Healthcare Products Regulatory Agency approved Alyftrek (vanzacaftor, tezacaftor, and deutivacaftor) as a cystic fibrosis…